CRISPR Therapeutics AG (CRSP): Next-Year EPS Estimate 25.83%
As of 2026-06-04, CRISPR Therapeutics AG (CRSP) has a next-year EPS growth estimate of 25.83%.
CRSP was first flagged by our screen on 2026-05-28 with a next-year EPS growth estimate of 25.82%. Since detection, the estimate has risen to 25.83% — a net gain of 0.01 percentage points across 1 upward revision. Current-year growth is projected at 24.66%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.83%
- EPS growth this year
- 24.66%
- EPS next quarter (est)
- -$1.20
- Last price
- $56.95
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 25.83% | 24.66% | -$1.20 | $56.95 |
| 2026-06-03 | 25.83% | 24.66% | -$1.20 | $52.08 |
| 2026-06-02 | 25.83% | 24.66% | -$1.20 | $52.02 |
| 2026-06-01 | 25.82% | 24.67% | -$1.20 | $54.19 |
| 2026-05-31 | 25.82% | 24.67% | -$1.20 | $56.18 |
| 2026-05-28 | 25.82% | 24.67% | -$1.20 | $56.38 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is CRISPR Therapeutics AG's next-year EPS growth estimate?▾
As of 2026-06-04, CRISPR Therapeutics AG (CRSP) has a next-year EPS growth estimate of 25.83%, based on analyst consensus.
When was the latest EPS estimate revision for CRSP?▾
The most recent revision occurred on 2026-06-02, when analysts adjusted the next-year EPS growth estimate from 25.82% to 25.83%.
What sector and industry does CRISPR Therapeutics AG belong to?▾
CRISPR Therapeutics AG operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. CRSP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. CRISPR Therapeutics AG (CRSP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports